Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy.

Transl Lung Cancer Res · 2020 · PMC7481587 · PMID 32953481

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

a trend toward significanceP=0.076so close (0.05 < p ≤ 0.1)

The median OS of VS-G in NSCLC patients treated with ICIs was longer than VS-P with a trend toward significance (P=0.076) ( Figure 2D ).

also in 3,328 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.